Optimization of analytical and pre-analytical conditions for MALDI-TOF-MS human urine protein profiles

Journal of Pharmaceutical and Biomedical Analysis

Volumn 51, Issue 4, 2010, Pages 907-914

  Calvano, C D ^a   Aresta, A ^a   Iacovone, M ^a   De Benedetto, G E ^b   Zambonin, C G ^a   Battaglia, M ^a   Ditonno, P ^a   Rutigliano, M ^a   Bettocchi, C ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF SALENTO   (Italy)

Author keywords

MALDI TOF MS; Prostate cancer; Proteomics; Sample preparation; Urine samples

Indexed keywords

ACIDIFICATION; ARTICLE; ARTIFACT REDUCTION; CENTRIFUGATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; HUMAN; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; REPRODUCIBILITY; STORAGE TEMPERATURE; URINALYSIS;

ARTIFACTS; CASE-CONTROL STUDIES; CHROMATOGRAPHY, ION EXCHANGE; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; NEOPLASM PROTEINS; PRINCIPAL COMPONENT ANALYSIS; PROSTATIC NEOPLASMS; PROTEIN STABILITY; PROTEOMICS; REPRODUCIBILITY OF RESULTS; SPECIMEN HANDLING; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TEMPERATURE; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 72149116700     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2009.10.014     Document Type: Article

References (28)

1. Adachi J., Kumar C., Zhang Y., Olsen J.V., and Mann M. The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins. Genome Biol. 7 (2006) 1-16
2. Cui S., Verroust P.J., Moestrup S.K., and Christensen E.I. Megalin/gp330 mediates uptake of albumin in renal proximal tubule. Am. J. Physiol. 271 (1996) F900-F907
3. Pisitkun T., Shen R.F., and Knepper M.A. Identification and proteomic profiling of exosomes in human urine. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 13368-13373
4. Castagna A., Cecconi D., Sennels L., Rappsilber J., Guerrier L., Fortis F., Boschetti E., Lomas L., and Righetti P.G. Exploring the hidden human urinary proteome via ligand library beads. J. Proteome Res. 4 (2005) 1917-1930
5. Pieper R., Gatlin C.L., McGrath A.M., Makusky A.J., Mondal M., Seonarain M., Field E., Schatz C.R., Estock M.A., Ahmed N., Anderson N.G., and Steiner S. Characterization of the human urinary proteome: a method for high-resolution display of urinary proteins on two-dimensional electrophoresis gels with a yield of nearly 1400 distinct protein spots. Proteomics 4 (2004) 1159-1174
6. Sun W., Li F., Wu S., Wang X., Zheng D., Wang J., and Gao Y. Human urine proteome analysis by three separation approaches. Proteomics 5 (2005) 4994-5001
7. Wang L., Li F., Sun W., Wu S., Wang X., Zhang L., Zheng D., Wang J., and Gao Y. Concanavalin A captured glycoproteins in healthy human urine. Mol. Cell Proteomics 5 (2006) 560-562
8. Locatelli F., Canaud B., Eckardt K.U., Stenvinkel P., Wanner C., and Zoccali C. The importance of diabetic nephropathy in current nephrological practice. Nephrol. Dial. Transplant 18 (2003) 1716-1725
9. Sarosdy M.F., deVere White R.W., Soloway M.S., Sheinfeld J., Hudson M.A., Schellhammer P.F., Jarowenko M.V., Adams G., and Blumenstein B.A. Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer. J. Urol. 154 (1995) 379-384
10. Soloway M.S., Briggman V., Carpinito G.A., Chodak G.W., Church P.A., Lamm D.L., Lange P., Messing E., Pasciak R.M., Reservitz G.B., Rukstalis D.B., Sarosdy M.F., Stadler W.M., Thiel R.P., and Hayden C.L. Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment. J. Urol. 156 (1996) 363-367
11. Katayama M., Hino F., Kamihagi K., Sekiguchi K., Titani K., and Kato I. Urinary fibronectin fragments (a potential tumor marker) measured by immunoenzymometric assay with domain-specific monoclonal antibodies. Clin. Chem. 37 (1991) 466-471
12. Sanchez-Carbayo M., Urrutia M., Gonzalez de Buitrago J.M., and Navajo J.A. Evaluation of two new urinary tumor markers: bladder tumor fibronectin and cytokeratin 18 for the diagnosis of bladder cancer. Clin. Cancer Res. 6 (2000) 3585-3594
13. Schmetter B.S., Habicht K.K., Lamm D.L., Morales A., Bander N.H., Grossman H.B., Hanna M.G., Silberman S.R., and Butman B.T. A multicenter trial evaluation of the fibrin/fibrinogen degradation products test for detection and monitoring of bladder cancer. J. Urol. 158 (1997) 801-805
14. González-Buitrago J.M., Ferreira L., and Lorenzo I. Urinary proteomics. Clin. Chim. Acta 375 (2007) 49-56
15. Theodorescu D., and Mischak H. Mass spectrometry based proteomics in urine biomarker discovery. World J. Urol. 25 (2007) 435-443
16. Papale M., Pedicillo M.C., Thatcher B.J., Di Paolo S., Lo Muzio L., Bufo P., Rocchetti M.T., Centra M., Ranieri E., and Gesualdo L. Urine profiling by SELDI-TOF/MS: monitoring of the critical steps is sample collection, handling and analysis. J. Chromatogr. B 856 (2007) 205-213
17. Gika H.G., Theodoridis G.A., and Wilson I.D. Liquid chromatography and ultra-performance liquid chromatography-mass spectrometry fingerprinting of human urine. Sample stability under different handling and storage conditions for metabonomics studies. J. Chromatogr. A 1189 (2008) 314-322
18. Amado F.M.L., Dominigues P., Santa-Marques M.G., Ferre-Correia A.J., and Tomer K.B. Discrimination effects and sensitivity variations in matrix-assisted laser desorption/ionization. Rapid Commun. Mass Spectrom. 11 (1997) 1347-1352
19. Kratzer R., Eckerskon C., Karas M., and Lottspeich F. Suppression effects in enzymatic peptide ladder sequencing using ultraviolet-matrix assisted laser desorption/ionization-mass spectrometry. Electrophoresis 19 (1998) 1910-1919
20. Aresta A., Calvano C.D., Palmisano F., Zambonin C.G., Monaco A., Tommasi S., Pilato B., and Paradiso A. Impact of sample preparation in peptide/protein profiling in human serum by MALDI-TOF mass spectrometry. J. Pharm. Biomed. Anal. 46 (2008) 157-164
21. Calvano C.D., Zambonin C.G., and Jensen O.N. Assessment of lectin and HILIC based enrichment protocols for characterization of serum glycoproteins by mass spectrometry. J. Proteomics 71 (2008) 304-317
22. Pyo J., Hwang S.I., Oh J., Lee S.J., Kang S.C., Kim J.S., and Lim J. Characterization of a bovine pregnancy-associated protein using two-dimensional gel electrophoresis, N-terminal sequencing and mass spectrometry. Proteomics 3 (2003) 2420-2427
23. Hwang S., and Lim J.K. Purification of bovine pregnancy-associated proteins by two dimensional gel electrophoresis. J. Biochem. Mol. Biol. 32 (1999) 445-450
24. Oh J., Pyo J.H., Jo E.H., Hwang S.I., Kang S.C., Jung J.H., Park E.K., Kim S.Y., Choi J.Y., and Lim J. Establishment of a near-standard two-dimensional human urine proteomic map. Proteomics 4 (2004) 3485-3497
25. Richter R., Schulz-Knappe P., Schräder M., Standker L., Jürgens M., and Forssmann W.G. Composition of the peptide fraction in human blood plasma: database of circulating human peptides. J. Chromatogr. B 726 (1999) 25-35
26. Lapolla A., Seraglia R., Molin L., Williams K., Cosma C., Reitano R., Sechi A., Ragazzi E., and Traldi P. Low molecular weight proteins in urines from healthy subjects as well as diabetic, nephropathic and diabetic-nephropathic patients: a MALDI study. J. Mass Spectrom. 44 (2009) 419-425
27. M'Koma A.E., Blum D.L., Norris J.L., Koyama T., Billheimer D., Motley S., Ghiassi M., Ferdowsi N., Bhowmick I., Chang S.S., Fowke J.H., Caprioli R.M., and Bhowmick N.A. Detection of pre-neoplastic and neoplastic prostate disease by MALDI profiling of urine. Biochem. Biophys. Res. Commun. 353 (2007) 829-834
28. Okamoto A., Yamamoto H., Imai A., Hatakeyama S., Iwabuchi I., Yoneyama T., Hashimoto Y., Koie T., Kamimura N., Mori K., Yamaya K., and Ohyama C. Protein profiling of post-prostatic massage urine specimens by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to discriminate between prostate cancer and benign lesions. Oncol. Rep. 21 (2009) 73-79